|
If you are interested in participating in any of the following
studies please take a look at our General
Research Brochure and our Contact page. They contain useful information that will
help you to make an informed decision regarding research participation
and also includes a glossary of terms often used to describe our
studies. If you are interested in taking part in one of the following trials, please call or e-mail us for more information.
Drug and Alcohol Dependence:
• Prescription Opiate Addiction Treatment Study (POATS)
A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone
Treatment Plus Individual Drug Counseling for Opioid Analgesic (pain killers) Dependence. No longer recruiting.
• Opiate Relapse Prevention Using Naltrexone for Parolees/Probationers
Study to examine the effectiveness of depot Naltrexone in preventing relapse in parolees and probationers with a history of opioid addiction. Currently recruiting. Please call 917-992-8651 for more information.
• Acamprosate Treatment of Methamphetamine Dependence
Placebo Control, Double Blind, Randomized Trial of Acamprosate for the Treatment of Methamphetamine Dependence. Currently recruiting.
• Methamphetamine Brain Imaging Study
White Matter Changes in Methamphetamine Abuse.
• Varenicline Treatment in Cigarette Smokers
Placebo-Controlled Study of Varenicline Effects on Nicotine Withdrawal Followed by a Test of Smoking Topography, Reward, and Reinforcement. Currently recruiting.
• Cue-Induced Cocaine Craving Study
A Placebo-Controlled Study of Valproate Effects on Cue-Induced
Cocaine Craving. No longer recruiting.
• Bupropion Treatment of Methamphetamine Dependence
NIDA-MDS-BupropionMeth-0001. Currently recruiting.
• Aprepitant Treatment in Methadone Patients
A placebo controlled trial of aprepitant for the management of opioid withdrawal in methadone maintained patients. Currently recruiting.
• Cocaine Vaccine Study
Multisite Controlled Trial of Cocaine Vaccine (5 of 6) New York University Treatment Site. Plan to begin recruitment Fall 2009.
• Brain Imaging Study of Cocaine Addiction
Functional and Structural Connectivity in Cocaine Addiction. No longer recruiting.
• Study of Vivitrol in Alcohol Dependence
Extended-release Naltrexone (Vivitrol) for Treatment of Alcohol Dependence in Urban Primary Care. Closed to patient entry.
• Patient Feedback Study
Patient Feedback Study: Feasibility of a patient-focused research study at outpatient treatment programs. Active.
• Mentorship for Alcohol Problems (MAP-Alcohol). Currently recruiting.
• Mentorship for Addiction Problems to Aid in Engagement to Treatment (MAP-Engage). Currently recruiting.
Attention Deficit Hyperactivity Disorder (ADHD):
Please view our ADHD Brochure for more information.
• Dosing Study of Concerta for the treatment of Adult ADHD
A Placebo-controlled, Double-blind, Parallel-group, Individualized Dosing Study Optimizing Treatment of Adults with Attention Deficit Hyperactivity Disorder to an Effective Response with OROS® Methylphenidate: OTTER Study. Plan to begin recruitment Fall 2009.
• ADHD Symptom Rating Scale Study for Adolescents
Comparison of Self
and Clinician Administered Ratings of Symptoms in Patients with
Attention Deficit Hyperactivity Disorder (ADHD). No longer recruiting.
• Adult ADHD Treatment With Vyvanse
Effectiveness and Duration of Effect of Open Treatment in Adult ADHD Patients Treated with Lisdexamfetamine Dimesylate –LDX (Vyvanse). No longer recruiting.
• fMRI Study of ADHD and Executive Function
A Functional Magnetic Resonance Imaging (fMRI) Study of the Impact of Reward Anticipation on Executive Function in Adolescents and Adults with ADHD and Normal Controls.
• Comparison Study of Immediate Release and Extended Release Adderall
A Within-Subject Cross-over Comparison between Immediate Release and Extended Adderall. No longer recruiting.
• ADHD Treatment with Atomoxetine in a Residential Substance Abuse Treatment Facility
A 10-Week Open Label Trial of Atomoxetine for ADHD was given to Patients with Substance Abuse Disorder and ADHD at Odyssey House. No longer recruiting.
Neuroimaging:
• fMRI Study of ADHD and Executive Function
A Functional Magnetic Resonance Imaging (fMRI) Study of the Impact of Reward Anticipation on Executive Function in Adolescents and Adults with ADHD and Normal Controls.
• Brain Imaging Study of Cocaine Addiction
Functional and Structural Connectivity in Cocaine Addiction. No longer recruiting.
• Methamphetamine Brain Imaging Study
White Matter Changes in Methamphetamine Abuse.
Other States of Pathological Restlessness:
• Incidence of Akathisia in Patients Treated with Aripiprazole. No longer recruiting.
Other Ongoing Studies:
• Prazosin Treatment for Veterans with War Zone Trauma PTSD
VA Cooperative Study #563: Prazosin Treatment for Combat Trauma PTSD. Plan to begin recruitment in November 2009.
• Risperidone Consta Treatment for Veterans with Schizophrenia
VA Cooperative Study #555: Long-Acting Injectable Risperidone
in the Treatment of Schizophrenia. No longer recruiting.
Healthy Controls:
• We are not currently recruiting healthy controls.
|